Literature DB >> 23445463

Risk factors of erectile dysfunction in patients receiving methadone maintenance therapy.

Nik Ruzyanei Nik Jaafar1, Noormazita Mislan, Salina Abdul Aziz, Azlin Baharudin, Normala Ibrahim, Marhani Midin, Srijit Das, Hatta Sidi.   

Abstract

INTRODUCTION: While methadone effectively treats opiate dependence, the side effect of erectile dysfunction (ED) may interfere with treatment adherence and benefits. AIM: To determine the rate of ED and the associated factors which predict ED in male patients on methadone maintenance therapy (MMT) in a Malaysian population. MAIN OUTCOME MEASURES: The main outcome measures were the International Index of Erectile Function-15 (IIEF-15) and the Beck Depression Inventory (BDI).
METHODS: A total of 108 participants diagnosed with heroin dependence were assessed. We used the Structured Clinical Interview for DSM-IV Axis-I Disorders (SCID-I) on subjects who received MMT, and they were assessed using the IIEF-15, the BDI, and measures of other clinical and sociodemographic variables.
RESULTS: The rate of ED among men on MMT was 68.5% (mild ED, 36.1%; mild to moderate ED, 22.2%; severe ED, 3.7%). The mean age of the participants was 43.45 years. Older age (P = 0.002), concurrent illicit heroin use (P = 0.024), and having an older partner (P = 0.039) were significantly associated with ED. Following multivariate analysis, it was found that older age was the only significant predictor of ED, with an adjusted odds ratio of 1.07 (95% CI = 1.02-1.16). Methadone dose and duration of methadone treatment were not significantly associated with ED.
CONCLUSION: ED was highly prevalent among male patients on MMT. This suggests that there is a need for routine assessment of sexual function in patients on methadone. Among the risk factors, age was the only factor that was significantly associated with ED. The current use of MMT in Malaysia in terms of dosage and duration did not pose a significant risk for ED.
© 2013 International Society for Sexual Medicine.

Entities:  

Keywords:  Erectile Dysfunction; Methadone Therapy; Opiate Dependence

Mesh:

Substances:

Year:  2013        PMID: 23445463     DOI: 10.1111/jsm.12105

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  6 in total

Review 1.  Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study.

Authors:  A Yee; H S Loh; H M B Hisham Hashim; C G Ng
Journal:  Int J Impot Res       Date:  2014-07-03       Impact factor: 2.896

2.  Treatments of Sexual Dysfunction in Opioid Substitution Therapy Patients: A Systematic Review and Meta-Analysis.

Authors:  Fitri Fareez Ramli; Muhammad Hasif Azizi; Syed Alhafiz Syed Hashim
Journal:  Int J Med Sci       Date:  2021-04-12       Impact factor: 3.738

3.  A conjugate vaccine attenuates morphine- and heroin-induced behavior in rats.

Authors:  Qian-Qian Li; Cheng-Yu Sun; Yi-Xiao Luo; Yan-Xue Xue; Shi-Qiu Meng; Ling-Zhi Xu; Na Chen; Jia-Hui Deng; Hai-Feng Zhai; Thomas R Kosten; Jie Shi; Lin Lu; Hong-Qiang Sun
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-07       Impact factor: 5.176

Review 4.  Sexual dysfunction in patients with alcohol and opioid dependence.

Authors:  Sandeep Grover; Surendra K Mattoo; Shreyas Pendharkar; Venkatesh Kandappan
Journal:  Indian J Psychol Med       Date:  2014-10

5.  Health-Seeking Behavior for Erectile Dysfunction in Methadone Maintenance Treatment Patients.

Authors:  Fitri Fareez Ramli; Ahmad Nazrun Shuid; Rashidi Mohamed Pakri Mohamed; Tg Mohd Ikhwan Tg Abu Bakar Sidik; Isa Naina Mohamed
Journal:  Int J Environ Res Public Health       Date:  2019-11-01       Impact factor: 3.390

6.  Substances of abuse consumption among patients seeking medical help for uro-andrological purposes: a sociobehavioral survey in the real-life scenario.

Authors:  Federico Belladelli; Luca Boeri; Paolo Capogrosso; Walter Cazzaniga; Eugenio Ventimiglia; Luigi Candela; Edoardo Pozzi; Andrea Baudo; Massimo Alfano; Costantino Abbate; Francesco Montorsi; Andrea Salonia
Journal:  Asian J Androl       Date:  2021 Sep-Oct       Impact factor: 3.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.